Integra Lifesciences Holdings (IART) Income from Discontinued Operations (2014 - 2015)
Integra Lifesciences Holdings' (IART) quarterly Income from Discontinued Operations came in at -$7.0 million in Q2 2015, down 109.74% quarter-over-quarter from -$3.3 million in Q1 2015.
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Income from Discontinued Operations (2014 - 2015) Analysis & Trends
Integra Lifesciences Holdings has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting -$7.0 million for Q2 2015.
- In Q2 2015, Income from Discontinued Operations changed N/A year-over-year to -$7.0 million; the TTM figure through Mar 2016 stood at -$7.0 million (changed N/A YoY), while the FY2015 annual figure was -$10.4 million, down 352.64% from the prior year.
- Income from Discontinued Operations came in at -$7.0 million for Q2 2015 at Integra Lifesciences Holdings, down from -$3.3 million in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $817000.0 in Q3 2014 to a low of -$7.0 million in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | -7.02 Mn |
| Mar 31, 2015 | -3.35 Mn |
| Dec 31, 2014 | -3.24 Mn |
| Sep 30, 2014 | 817,000.00 |